Literature DB >> 14050794

THE OCCURRENCE OF HEINZ BODIES DURING AZULFIDINE TREATMENT OF ULCERATIVE COLITIS.

L E BOETTIGER, L ENGSTEDT, R LAGERCRANTZ, A NYBERG.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC; COLITIS, ULCERATIVE; HEINZ BODIES; STATISTICS; SULFONAMIDES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14050794     DOI： 10.1159/000202343

Source DB:  PubMed          Journal:  Gastroenterologia        ISSN： 0301-164X


× No keyword cloud information.
  4 in total

1.  Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.

Authors:  R E Pounder; E R Craven; J S Henthorn; J M Bannatyne
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

3.  Agranulocytosis associated with sulphasalazine therapy.

Authors:  P Cochrane; P Atkins; S Ehsanullah
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

4.  Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.

Authors:  A K Azad Khan; D T Howes; J Piris; S C Truelove
Journal:  Gut       Date:  1980-03       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.